Bleeding in the brain in very premature babies
Part of Brain & nervous system clinical trials.
This study looks at the outcomes of brain bleeding (intraventricular hemorrhage) in very premature babies. It aims to understand how these babies do and what helps them, which may lead to better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be born before 34 weeks of pregnancy.
- Your baby must weigh less than 1500 grams (about 3 pounds 5 ounces) at birth.
- Your baby must be admitted to the NICU within 24 hours of being born.
- Your baby should not have major birth defects, especially of the brain or spinal cord.
- Your baby should not have had severe oxygen deprivation around the time of birth.
- Your baby should not have a serious infection present at birth (like TORCH).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies better ways to prevent, catch early, and treat brain bleeds in premature babies. It focuses on babies who already have a brain bleed that causes fluid buildup (hydrocephalus) but haven't received any drainage treatment yet.
This Phase 1 trial studies whether giving erythropoietin (EPO) and melatonin is safe in very preterm infants who have bleeding in the brain (intraventricular hemorrhage) or significant nearby brain injury. It aims to see if these medicines can be given safely during the early days after birth.
This trial tests a light therapy device in newborns who had a severe form of brain bleeding (intraventricular hemorrhage grade 3 or 4) within the first month of life. The goal is to see if this non-invasive treatment may help improve recovery.
This study follows newborns and premature babies who had bleeding in the brain (intra-cranial or within the brain’s fluid spaces). It looks at long-term outcomes to better understand what happens over time and support families with care planning.
This study uses advanced MRI scans to look at the brains of newborns who have had bleeding in the brain (IVH) and developed a condition called PHVD (fluid buildup after bleeding). The goal is to learn more about the brain and how it is affected, which could help improve care for these babies.
This trial tests a treatment called neuroendoscopic lavage—a way to wash out a severe brain bleed in newborns using a tiny camera. It may help prevent fluid buildup and brain damage. Doctors want to see if it works better than regular care for babies under one month old with this condition.
Hear when a new Intraventricular Hemorrhage of Prematurity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.